Fulgent Genetics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FLGT, updated each market day.
FLGT AI Sentiment
AI sees no strong directional signal for Fulgent Genetics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Fulgent Genetics, Inc. Common Stock
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Sector
Exchange
Market Cap
$433,246,162
Cap Tier
Employees
1,315
Headquarters
EL MONTE, CA
Listed Since
Sept. 29, 2016
Website
FLGT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FLGT Volatility
Fulgent Genetics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
